| Stage 2 | in sCr > 2.0 - 3.0 × baseline |
| Stage 3 | in sCr >3.0 × baseline or sCr ≥ 4.0 mg/dL with an acute ≥ 0.5 mg/dL or initiation of RRT |
| KDIGO | |
| an acute in sCr within 48 h | |
| Stage 1 | in sCr ≥ 1.5 - 1.9 × baseline or in sCr ≥ 0.3 mg/dL |
| Stage 2 | in sCr ≥ 2.0 - 2.9 × baseline |
| Stage 3 | in sCr ≥ 3.0 × baseline or sCr ≥ 4.0 mg/dL with an acute ≥ 0.5 mg/dL or initiation of RRT |